PHOENIX, AZ | NOVEMBER 1-5

Experience G4 at AMP

Booth 1502

AMP Platform Presentation

Thursday, November 3, 2022, Room I006

Rapid Targeted Germline and Somatic Variant Detection Using the G4 Sequencing System

Presented by Timothy Looney, PhD, Singular Genomics Senior Director Scientific Affairs

 

Data

Application Notes

Learn More About the G4

G4 Reagents

Explore G4 Sequencing Kits and specifications.

G4 SUPPORT HUB​

Access G4 support materials and documentation.

G4 COST EFFICIENCY​

Unlock cost savings and lab flexibility with the G4.

G4 WORKFLOW​

Review the plug-and-play capabilities of the G4 Sequencing Platform.

Innovation with Intention

Featuring novel, high-performance chemistry and advanced engineering, the G4 Sequencing Platform has been optimized to deliver speed, power, unprecedented flexibility, and accuracy.

Connect with us at AMP

Please provide your information and a member of the Singular Genomics team will be in contact about meeting at AMP.

Download Singular Genomics Single Cell RNA-Seq Poster

Please provide your information to download the poster.

Download the HD-Seq Poster

Please provide your information to download the poster.

Download the Max Read Poster

Please provide your information to download the poster.

Download the Whole Genome and Whole Exome Variant Poster

Please provide your information to download the poster.

Download the JGI Poster

Please provide your information to download the poster.

Download Resolution Bioscience Poster

Please provide your information to download the poster.

Download TGen Poster

Please provide your information to download the poster.

Download the Whole Genome Sequencing Application Note

Please provide your information to download the application note.

Download the RNA Sequencing Application Note

Please provide your information to download the applicatiom note.

Download the Whole Exome Sequencing Application Note

Please provide your information to download the application note.

Download the Single Cell RNA Sequencing Application Note

Please provide your information to download the application note.

Drew Spaventa

Drew founded Singular Genomics in 2016 serving as the CEO and Chairman. Drew is a serial entrepreneur and venture investor in the biotech industry and has been involved in the founding of several successful companies. Prior to Singular Genomics, Drew founded Truvian Sciences, a low volume blood testing technology aimed at making routine blood tests easier, less invasive, and more affordable. Drew was also involved in the founding of Aspen Neurosciences where he co-led the seed financing and helped assemble a world-class team to combat Parkinson’s Disease using a patient’s own stem cells. Drew was also a seed investor and held an operating role in Edico Genome which sold to Illumina in 2018.

Drew received an MBA from the Rady School of Management at the University of California, San Diego and a BA in Political Science and International Relations from the University of California, San Diego.

Max Reads Application Note